Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.

Cancers (Basel) · 2022 · PMC8909561 · PMID 35267558

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

showed a trendp = 0.077so close (0.05 < p ≤ 0.1)

According to a genomic study of a subset of RADIANT everolimus trials [ 248 ], patients with high chromosomal instability (CIN) showed a trend toward longer OS (HR, 0.55; p = 0.077), even after adjusting for baseline CgA/NSE levels (HR, 0.53; p = 0.068).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.